Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,830 | 46,478 | 31,969 | 24,352 | 90,763 |
| Marketable Securities | 8,064 | N/A | 18,448 | 15,430 | N/A |
| Receivables | 26,563 | 27,801 | 13,671 | 6,135 | 3,903 |
| Inventories | 11,010 | 10,367 | 11,732 | 5,767 | 2,520 |
| Other current assets | 4,092 | 4,032 | 3,575 | 3,585 | 1,058 |
| TOTAL | $66,559 | $88,678 | $79,395 | $55,269 | $98,244 |
| Non-Current Assets | |||||
| PPE Net | 7,345 | 7,914 | 8,203 | 7,076 | 5,124 |
| Intangibles | 12,543 | 14,616 | 16,348 | 17,647 | 16,672 |
| Other Non-Current Assets | 4,426 | 149 | 162 | 150 | 2,470 |
| TOTAL | $24,314 | $22,679 | $24,713 | $24,873 | $24,266 |
| Total Assets | $90,873 | $111,357 | $104,108 | $80,142 | $122,510 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 15,836 | 8,557 | 896 | 4,921 | 7,973 |
| Accounts payable and accrued liabilities | 6,650 | 12,730 | 11,460 | 7,798 | 4,824 |
| Accrued Expenses | 40,188 | 35,818 | 20,944 | 5,264 | 3,141 |
| TOTAL | $63,355 | $57,105 | $33,300 | $21,645 | $15,938 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,099 | 43,217 | 58,938 | 58,599 | 26,271 |
| Deferred Revenues | N/A | N/A | N/A | 3,662 | N/A |
| Other Non-Current Liabilities | 4,549 | 2,201 | 1,840 | 272 | 214 |
| TOTAL | $33,648 | $46,407 | $61,861 | $60,045 | $28,198 |
| Total Liabilities | $97,003 | $103,512 | $95,161 | $81,690 | $44,136 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,743 | 49,711 | 28,997 | 22,561 | 16,035 |
| Common Shares | 50 | 50 | 29 | 16 | 16 |
| Retained earnings | -333,885 | -316,983 | -265,308 | -200,118 | -116,785 |
| Other shareholders' equity | -351 | -352 | -358 | -233 | -171 |
| TOTAL | $-6,130 | $7,845 | $8,947 | $-1,548 | $78,374 |
| Total Liabilities And Equity | $90,873 | $111,357 | $104,108 | $80,142 | $122,510 |